A number of recent Congressional hearings have focused on health policy issues, including:
- A House Energy and Commerce Health Subcommittee hearing on “Drug Safety: An Update from the FDA”;
- A Senate Homeland Security and Governmental Affairs Committee, Federal Financial Management Subcommittee hearing on oversight challenges in the Medicare Part D prescription drug program;
- Two House hearings focused on efforts to combat health care fraud and abuse, one by the Judiciary Subcommittee on Crime, Terrorism and Homeland Security, and the other by the Appropriations Labor-HHS Subcommittee; and
- A House Oversight and Government Reform Committee hearing on “Prostate Cancer: New Questions About Screening and Treatment.”
In addition, the Senate Special Committee on Aging has scheduled a March 17 hearing on rising drug prices and the Part D program.